Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
160 participants
OBSERVATIONAL
2024-02-20
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Do echocardiographic and electrocardiographic parameters relating to cardiac stunning predict atrial fibrillation (AF) recurrence rates after electrical cardioversion?
Participants will undergo echocardiography and a 24-hour Holter monitoring immediately after electrical cardioversion.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atrial fibrillation
A group of patients with atrial fibrillation refractory to pharmacological treatment who are candidates for electrical cardioversion
electrical cardioversion
synchronized electrical shocks to restore normal sinus rhythm in patients with atrial fibrillation, performed under sedation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electrical cardioversion
synchronized electrical shocks to restore normal sinus rhythm in patients with atrial fibrillation, performed under sedation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with persistent or symptomatic atrial fibrillation who are candidates for electrical cardioversion
* Patients eligible for anticoagulation therapy for thromboembolism prevention before and after the procedure
* Patients who can understand and provide written informed consent
Exclusion Criteria
* Patients who do not consent to participate in the study
* Patients with severe coronary artery stenosis
* Patients with severe hepatic dysfunction
* Patients with severe renal dysfunction
* Patients with severe valvular heart disease
* Patients with a high risk of severe bleeding
* Patients with a history of atrial fibrillation-related catheter ablation or cardiac surgery
* Patients with an expected life expectancy of less than 1 year
* Potentially pregnant individuals
* Patients deemed unsuitable for the study by the investigator
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University Guro Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roh Seung Young
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Korea University Medicine Guro hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020GR0213
Identifier Type: -
Identifier Source: org_study_id